// App-Quantinova.ai

871 : Nanoliposomal targeting of ephrin receptor A2 (EphA2): Preclinical in vitro and in vivo rationale

Researchers

Presenter

  • Walid S. Kamoun

Principal Investigators

  • Lia Luus

  • Christine Pien

  • Tad Kornaga

  • Shinji Oyama

  • Zhaohua Richard Huang

  • Suresh Tipparaju

  • Dmitri B. Kirpotin

  • James D. Marks

  • Alexander Koshkaryev

  • Melissa Geddie

  • Lihui Xu

  • Alexey Lugovosky

  • Daryl C. Drummond

Medical Centers

  • Merrimack, Cambridge, MA

  • UCSF, San Francisco, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Lung Cancer

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

  • MM310

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved